BamSEC and AlphaSense Join Forces
Learn More

Salarius Pharmaceuticals Inc.

NASDAQ: SLRX    
Share price (10/17/25): $4.11    
Market cap (10/17/25): $2.095 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3
from 8-K 16 pages Terms of Series B Preferred Stock
12/34/56
EX-2.2
from 8-K 16 pages Terms of Series a Preferred Stock
12/34/56
EX-2.1
from 8-K 5 pages Fifth Amendment to Agreement and Plan of Merger
12/34/56
EX-2.3
from 8-K 16 pages Terms of Series B Preferred Stock
12/34/56
EX-2.2
from 8-K 15 pages Terms of Series a Preferred Stock
12/34/56
EX-2.1
from 8-K 5 pages Fourth Amendment to Agreement and Plan of Merger
12/34/56
EX-2.2
from 8-K 16 pages Terms of Series B Preferred Stock
12/34/56
EX-2.1
from 8-K 7 pages Third Amendment to Agreement and Plan of Merger
12/34/56
EX-2.2
from 8-K 16 pages Terms of Series a Preferred Stock
12/34/56
EX-2.1
from 8-K 5 pages Second Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 6 pages First Amendment to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 116 pages Agreement and Plan of Merger by and Among Salarius Pharmaceuticals, Inc., a Delaware Corporation; Decoy Therapeutics Mergersub I, Inc., a Delaware Corporation; Decoy Therapeutics Mergersub II, LLC, a Delaware Limited Liability Company; and Decoy Therapeutics Inc., a Delaware Corporation. Dated as of January 10, 2025
12/34/56
EX-2.1
from 8-K 22 pages Asset Purchase Agreement
12/34/56
EX-2.3
from 8-K 4 pages Waiver No. 1 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 2 pages Amendment No. 1 to Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 2 pages Amendment No. 1 to Agreement and Plan of Merger
12/34/56
EX-2.5
from 425 5 pages Lock-Up Agreement
12/34/56
EX-2.5
from 8-K 5 pages Lock-Up Agreement
12/34/56
EX-2.4
from 8-K 5 pages Lock-Up Agreement
12/34/56
EX-2.4
from 425 5 pages Lock-Up Agreement
12/34/56